Loading...

Genfit S.A.

GNFTF•PNK
Healthcare
Biotechnology
$11.05
$0.00(0.00%)
U.S. Market opens in 2h 9m

Genfit S.A. (GNFTF) Stock Overview

Explore Genfit S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap553.4M
P/E Ratio-5.49
EPS (TTM)$-2.01
ROE-5.96%
Fundamental Analysis

AI Price Forecasts

1 Month$10.25
3 Months$8.07
1 Year Target$5.56

GNFTF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Genfit S.A. (GNFTF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 69.70, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.56.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.49 and a market capitalization of 553.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
5.94%
3-Month Change
84.17%
6-Month Change
197.04%
Year-to-Date (YTD) Change
84.17%
1-Year Change
212.15%
3-Year Change
151.71%
5-Year Change
139.18%
All-Time (Max) Change
-61.57%

Contact Information

https://www.genfit.com
33 3 20 16 40 00
Parc EurasantE, Loos, NaN, 59120

Company Facts

180 Employees
IPO DateJan 27, 2014
CountryFR
Actively Trading

Frequently Asked Questions